Standard

Dosimetry for boron neutron capture therapy developed and verified at the accelerator based neutron source VITA. / Bikchurina, Marina; Bykov, Timofey; Ibrahim, Ibrahim и др.

в: Frontiers in Nuclear Engineering, Том 2, 1266562, 03.10.2023.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

APA

Vancouver

Bikchurina M, Bykov T, Ibrahim I, Kasatova A, Kasatov D, Kolesnikov I и др. Dosimetry for boron neutron capture therapy developed and verified at the accelerator based neutron source VITA. Frontiers in Nuclear Engineering. 2023 окт. 3;2:1266562. doi: 10.3389/fnuen.2023.1266562

Author

Bikchurina, Marina ; Bykov, Timofey ; Ibrahim, Ibrahim и др. / Dosimetry for boron neutron capture therapy developed and verified at the accelerator based neutron source VITA. в: Frontiers in Nuclear Engineering. 2023 ; Том 2.

BibTeX

@article{658b651a9028420d816090c0be9bce87,
title = "Dosimetry for boron neutron capture therapy developed and verified at the accelerator based neutron source VITA",
abstract = "The method of boron neutron capture therapy for malignant tumors, proposed in 1936, is beginning to enter clinical practice. The development of dosimetry tools for characterization of therapeutic mixed neutron-photon beam and assessing the patient{\textquoteright}s response to treatment is becoming relevant. In this work, a number of dosimetric techniques have been developed: a compact neutron detector with a pair of cast scintillators, one of which is enriched with boron, to measure the boron dose and the γ-ray dose; cell dosimeter for measuring the sum of the equivalent dose of fast neutrons and the equivalent nitrogen dose; prompt γ-ray spectroscopy for in situ measurement of boron dose in real time; epithermal neutron flux monitor for measuring the epithermal neutron flux. Their verification carried out on the accelerator based neutron source VITA showed that they can become convenient and reliable tools for characterization of neutron beam and assessing the patient{\textquoteright}s response to treatment. ",
author = "Marina Bikchurina and Timofey Bykov and Ibrahim Ibrahim and Anna Kasatova and Dmitrii Kasatov and Iaroslav Kolesnikov and Victoria Konovalova and Timur Kormushakov and Alexey Koshkarev and Anton Kuznetsov and Vyacheslav Porosev and Sergey Savinov and Ivan Shchudlo and Nataliia Singatulina and Evgeniia Sokolova and Tatiana Sycheva and Iuliia Taskaeva and Gleb Verkhovod and Sergey Taskaev",
note = "The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by Russian Science Foundation, grant number 19-72-30005, https://rscf.ru/project/19-72-30005/.",
year = "2023",
month = oct,
day = "3",
doi = "10.3389/fnuen.2023.1266562",
language = "English",
volume = "2",
journal = "Frontiers in Nuclear Engineering",
issn = "2813-3412",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Dosimetry for boron neutron capture therapy developed and verified at the accelerator based neutron source VITA

AU - Bikchurina, Marina

AU - Bykov, Timofey

AU - Ibrahim, Ibrahim

AU - Kasatova, Anna

AU - Kasatov, Dmitrii

AU - Kolesnikov, Iaroslav

AU - Konovalova, Victoria

AU - Kormushakov, Timur

AU - Koshkarev, Alexey

AU - Kuznetsov, Anton

AU - Porosev, Vyacheslav

AU - Savinov, Sergey

AU - Shchudlo, Ivan

AU - Singatulina, Nataliia

AU - Sokolova, Evgeniia

AU - Sycheva, Tatiana

AU - Taskaeva, Iuliia

AU - Verkhovod, Gleb

AU - Taskaev, Sergey

N1 - The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by Russian Science Foundation, grant number 19-72-30005, https://rscf.ru/project/19-72-30005/.

PY - 2023/10/3

Y1 - 2023/10/3

N2 - The method of boron neutron capture therapy for malignant tumors, proposed in 1936, is beginning to enter clinical practice. The development of dosimetry tools for characterization of therapeutic mixed neutron-photon beam and assessing the patient’s response to treatment is becoming relevant. In this work, a number of dosimetric techniques have been developed: a compact neutron detector with a pair of cast scintillators, one of which is enriched with boron, to measure the boron dose and the γ-ray dose; cell dosimeter for measuring the sum of the equivalent dose of fast neutrons and the equivalent nitrogen dose; prompt γ-ray spectroscopy for in situ measurement of boron dose in real time; epithermal neutron flux monitor for measuring the epithermal neutron flux. Their verification carried out on the accelerator based neutron source VITA showed that they can become convenient and reliable tools for characterization of neutron beam and assessing the patient’s response to treatment.

AB - The method of boron neutron capture therapy for malignant tumors, proposed in 1936, is beginning to enter clinical practice. The development of dosimetry tools for characterization of therapeutic mixed neutron-photon beam and assessing the patient’s response to treatment is becoming relevant. In this work, a number of dosimetric techniques have been developed: a compact neutron detector with a pair of cast scintillators, one of which is enriched with boron, to measure the boron dose and the γ-ray dose; cell dosimeter for measuring the sum of the equivalent dose of fast neutrons and the equivalent nitrogen dose; prompt γ-ray spectroscopy for in situ measurement of boron dose in real time; epithermal neutron flux monitor for measuring the epithermal neutron flux. Their verification carried out on the accelerator based neutron source VITA showed that they can become convenient and reliable tools for characterization of neutron beam and assessing the patient’s response to treatment.

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85186578235&origin=inward&txGid=e99534db715035ab33d74d95eb8ceb56

UR - https://www.mendeley.com/catalogue/0401ea4d-9b6b-30ed-b2dd-02a8d1e89166/

U2 - 10.3389/fnuen.2023.1266562

DO - 10.3389/fnuen.2023.1266562

M3 - Article

VL - 2

JO - Frontiers in Nuclear Engineering

JF - Frontiers in Nuclear Engineering

SN - 2813-3412

M1 - 1266562

ER -

ID: 61417356